ZA985710B - Delayed-release dosage forms of sertraline. - Google Patents

Delayed-release dosage forms of sertraline.

Info

Publication number: ZA985710B
Authority: ZA; South Africa
Prior art keywords: sertraline; delayed; dosage forms; release dosage; release
Prior art date: 1997-07-01

Application number

ZA9805710A

Other languages

English (en)

Inventor

William John Curatolo

Hylar Lewis Friedman

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-07-01

Filing date

1998-06-30

Publication date

2000-01-10

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971681&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA985710(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1998-06-30 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2000-01-10 Publication of ZA985710B publication Critical patent/ZA985710B/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Reproductive Health (AREA)
Endocrinology (AREA)
Child & Adolescent Psychology (AREA)
Molecular Biology (AREA)
Pain & Pain Management (AREA)
Gynecology & Obstetrics (AREA)
Diabetes (AREA)
Hematology (AREA)
Biophysics (AREA)
Addiction (AREA)
Obesity (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

ZA9805710A 1997-07-01 1998-06-30 Delayed-release dosage forms of sertraline. ZA985710B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US5149997P	1997-07-01	1997-07-01

Publications (1)

Publication Number	Publication Date
ZA985710B true ZA985710B (en)	2000-01-10

Family

ID=21971681

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA9805710A ZA985710B (en)	1997-07-01	1998-06-30	Delayed-release dosage forms of sertraline.

Country Status (40)

Country	Link
EP (1)	EP1007024B1 (xx)
JP (1)	JP3786715B2 (xx)
KR (1)	KR100369698B1 (xx)
CN (4)	CN1475209A (xx)
AP (1)	AP1199A (xx)
AR (1)	AR038394A2 (xx)
AT (1)	ATE245415T1 (xx)
AU (1)	AU727152B2 (xx)
BG (1)	BG64742B1 (xx)
BR (1)	BR9809895A (xx)
CA (1)	CA2290969C (xx)
DE (1)	DE69816624T2 (xx)
DK (1)	DK1007024T3 (xx)
DZ (1)	DZ2547A1 (xx)
EA (1)	EA001906B1 (xx)
ES (1)	ES2202858T3 (xx)
GT (1)	GT199800091A (xx)
HN (1)	HN1998000099A (xx)
HR (1)	HRP980376B1 (xx)
HU (1)	HUP0301787A3 (xx)
ID (1)	ID23187A (xx)
IL (2)	IL133081A (xx)
IS (1)	IS5267A (xx)
MA (1)	MA24585A1 (xx)
NO (1)	NO996519L (xx)
NZ (1)	NZ501249A (xx)
OA (1)	OA11247A (xx)
PA (1)	PA8454201A1 (xx)
PE (1)	PE84399A1 (xx)
PL (1)	PL337799A1 (xx)
PT (1)	PT1007024E (xx)
SI (1)	SI1007024T1 (xx)
SK (1)	SK173299A3 (xx)
TN (1)	TNSN98122A1 (xx)
TR (1)	TR199903295T2 (xx)
TW (1)	TW575437B (xx)
UA (1)	UA63953C2 (xx)
UY (1)	UY25068A1 (xx)
WO (1)	WO1999001122A1 (xx)
ZA (1)	ZA985710B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BRPI9914977B8 (pt)	1998-11-02	2021-05-25	Elan Corp Plc	composição multiparticulada de liberação modificada
CZ302388B6 (cs) *	1999-05-20	2011-04-27	Elan Pharma International Limited	Prostredky tvorené více cásticemi s regulovaným uvolnováním selektivního inhibitoru opakované absorpce serotoninu a jeho použití
IE990406A1 (en)	1999-05-20	2000-12-27	Elan Corp Plc	Multiparticulate controlled release selective serotonin reuptake inhibitor formulations.
NZ517038A (en)	1999-09-03	2003-04-29	Lilly Co Eli	Use of serotonin reuptake inihibitor in medicaments for treating sexual dysfunction
ES2168043B1 (es) *	1999-09-13	2003-04-01	Esteve Labor Dr	Forma farmaceutica solida oral de liberacion modificada que contiene un compuesto de bencimidazol labil en medio acido.
BRPI0108145B8 (pt) *	2000-02-10	2021-05-25	Bpsi Holdings Inc	composições de revestimento entérico acrílicas
AU2001276608A1 (en)	2000-08-30	2002-03-13	Pfizer Products Inc.	Sustained release formulations for growth hormone secretagogues
US6482440B2 (en) *	2000-09-21	2002-11-19	Phase 2 Discovery, Inc.	Long acting antidepressant microparticles
WO2002080887A2 (en) *	2001-04-10	2002-10-17	Sun Pharmaceutical Industries Limited	Timed pulse release composition
WO2003013480A1 (en) *	2001-08-06	2003-02-20	Dr. Reddy's Laboratories Ltd.	Improved enteric formulation of fluoxetin
GB0607534D0 (en) *	2006-04-13	2006-05-24	Univ London Pharmacy	Colonic drug delivery formulation
EP2586429A1 (en) *	2011-10-26	2013-05-01	Freund Pharmatec Ltd.	Multi-unit drug delivery device for pulsatile or sustained release
CN108014087A (zh) *	2017-12-27	2018-05-11	江苏联环药业股份有限公司	一种盐酸舍曲林胶囊的制备方法
CN109432038A (zh) *	2018-12-28	2019-03-08	乐普制药科技有限公司	一种含有盐酸舍曲林的肠溶片剂及其制备方法
CN114129540B (zh) *	2021-11-19	2022-07-05	浙江维康药业股份有限公司	一种肝苏胶囊及其制作方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK150008C (da) *	1981-11-20	1987-05-25	Benzon As Alfred	Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
US4803076A (en) *	1986-09-04	1989-02-07	Pfizer Inc.	Controlled release device for an active substance
IL91398A (en) *	1988-08-30	1994-05-30	Pfizer	Pharmaceutical delivery device comprising active substance surrounded by asymmetric membrane
EP0357364B1 (en) *	1988-08-30	1993-07-28	E.I. Du Pont De Nemours And Company	A process for flash-spinning dry polymeric plexifilamentary film-fibril strands
US4983401A (en) *	1989-05-22	1991-01-08	Kinaform Technology, Inc.	Sustained release pharmaceutical preparations having pH controlled membrane coatings

1998
- 1998-06-16 SI SI9830494T patent/SI1007024T1/xx unknown
- 1998-06-16 AU AU75451/98A patent/AU727152B2/en not_active Ceased
- 1998-06-16 WO PCT/IB1998/000937 patent/WO1999001122A1/en not_active Ceased
- 1998-06-16 SK SK1732-99A patent/SK173299A3/sk unknown
- 1998-06-16 CN CNA031489737A patent/CN1475209A/zh active Pending
- 1998-06-16 CA CA002290969A patent/CA2290969C/en not_active Expired - Fee Related
- 1998-06-16 AT AT98923022T patent/ATE245415T1/de not_active IP Right Cessation
- 1998-06-16 DE DE69816624T patent/DE69816624T2/de not_active Expired - Fee Related
- 1998-06-16 IL IL13308198A patent/IL133081A/xx not_active IP Right Cessation
- 1998-06-16 IL IL15230498A patent/IL152304A0/xx unknown
- 1998-06-16 UA UA99116392A patent/UA63953C2/uk unknown
- 1998-06-16 KR KR10-1999-7011529A patent/KR100369698B1/ko not_active Expired - Fee Related
- 1998-06-16 ES ES98923022T patent/ES2202858T3/es not_active Expired - Lifetime
- 1998-06-16 DK DK98923022T patent/DK1007024T3/da active
- 1998-06-16 PL PL98337799A patent/PL337799A1/xx unknown
- 1998-06-16 ID IDW991698A patent/ID23187A/id unknown
- 1998-06-16 PT PT98923022T patent/PT1007024E/pt unknown
- 1998-06-16 CN CNA200310118311XA patent/CN1494899A/zh active Pending
- 1998-06-16 EA EA199900965A patent/EA001906B1/ru unknown
- 1998-06-16 CN CNB988064294A patent/CN1151783C/zh not_active Expired - Fee Related
- 1998-06-16 CN CNA031489729A patent/CN1475208A/zh active Pending
- 1998-06-16 JP JP50677799A patent/JP3786715B2/ja not_active Expired - Fee Related
- 1998-06-16 HU HU0301787A patent/HUP0301787A3/hu unknown
- 1998-06-16 TR TR1999/03295T patent/TR199903295T2/xx unknown
- 1998-06-16 EP EP98923022A patent/EP1007024B1/en not_active Expired - Lifetime
- 1998-06-16 NZ NZ501249A patent/NZ501249A/en unknown
- 1998-06-16 BR BR9809895-0A patent/BR9809895A/pt not_active Application Discontinuation
- 1998-06-25 TW TW087110269A patent/TW575437B/zh active
- 1998-06-25 PA PA19988454201A patent/PA8454201A1/es unknown
- 1998-06-25 AP APAP/P/1998/001278A patent/AP1199A/en active
- 1998-06-26 PE PE1998000577A patent/PE84399A1/es not_active Application Discontinuation
- 1998-06-29 GT GT199800091A patent/GT199800091A/es unknown
- 1998-06-29 UY UY25068A patent/UY25068A1/es not_active IP Right Cessation
- 1998-06-30 MA MA25144A patent/MA24585A1/fr unknown
- 1998-06-30 ZA ZA9805710A patent/ZA985710B/xx unknown
- 1998-06-30 HN HN1998000099A patent/HN1998000099A/es unknown
- 1998-06-30 TN TNTNSN98122A patent/TNSN98122A1/fr unknown
- 1998-06-30 DZ DZ980157A patent/DZ2547A1/xx active
- 1998-07-01 HR HR980376A patent/HRP980376B1/xx not_active IP Right Cessation
1999
- 1999-11-23 BG BG103916A patent/BG64742B1/bg unknown
- 1999-11-23 IS IS5267A patent/IS5267A/is unknown
- 1999-12-23 OA OA9900307A patent/OA11247A/en unknown
- 1999-12-28 NO NO996519A patent/NO996519L/no not_active Application Discontinuation
2003
- 2003-02-05 AR ARP030100364A patent/AR038394A2/es active IP Right Grant

Also Published As

Publication number	Publication date
PT1007024E (pt)	2003-11-28
HK1027982A1 (en)	2001-02-02
KR100369698B1 (ko)	2003-01-30
HRP980376A2 (en)	1999-04-30
EA199900965A1 (ru)	2000-08-28
PA8454201A1 (es)	2000-09-29
AR038394A2 (es)	2005-01-12
BG64742B1 (bg)	2006-02-28
DE69816624T2 (de)	2004-02-19
CA2290969A1 (en)	1999-01-14
CN1261273A (zh)	2000-07-26
EA001906B1 (ru)	2001-10-22
WO1999001122A1 (en)	1999-01-14
CN1494899A (zh)	2004-05-12
AU7545198A (en)	1999-01-25
IL133081A (en)	2005-09-25
NO996519L (no)	2000-02-29
NZ501249A (en)	2001-06-29
ID23187A (id)	2000-03-23
EP1007024B1 (en)	2003-07-23
HN1998000099A (es)	1998-10-22
PL337799A1 (en)	2000-09-11
AU727152B2 (en)	2000-12-07
CN1475208A (zh)	2004-02-18
UY25068A1 (es)	2000-12-29
DE69816624D1 (de)	2003-08-28
HUP0301787A2 (hu)	2003-11-28
HUP0301787A3 (en)	2005-04-28
NO996519D0 (no)	1999-12-28
CN1475209A (zh)	2004-02-18
PE84399A1 (es)	1999-09-11
OA11247A (en)	2002-11-19
TR199903295T2 (xx)	2000-08-21
BG103916A (en)	2000-07-31
BR9809895A (pt)	2000-08-01
GT199800091A (es)	1999-12-21
IL152304A0 (en)	2003-05-29
CN1151783C (zh)	2004-06-02
JP2000513751A (ja)	2000-10-17
TW575437B (en)	2004-02-11
MA24585A1 (fr)	1998-12-31
DZ2547A1 (fr)	2003-02-08
IL133081A0 (en)	2001-03-19
ES2202858T3 (es)	2004-04-01
CA2290969C (en)	2004-02-17
JP3786715B2 (ja)	2006-06-14
SK173299A3 (en)	2000-11-07
SI1007024T1 (en)	2003-12-31
KR20010013522A (ko)	2001-02-26
IS5267A (is)	1999-11-23
AP1199A (en)	2003-08-28
HRP980376B1 (en)	2002-12-31
DK1007024T3 (da)	2003-11-17
ATE245415T1 (de)	2003-08-15
TNSN98122A1 (fr)	2005-03-15
EP1007024A1 (en)	2000-06-14
AP9801278A0 (en)	1998-06-30
UA63953C2 (uk)	2004-02-16

Publication	Publication Date	Title
GB2310601B (en)	1999-12-22	Paracetamol sustained-release formulation
ZA982253B (en)	1999-09-17	Therapeutic compositions.
ZA987551B (en)	1999-02-23	Solid pharmaceutical dosage forms
ZA987844B (en)	2000-02-28	Therapeutic combinations.
ZA989251B (en)	2000-04-10	Potentiation of pharmaceuticals.
ZA975673B (en)	1997-12-29	Solid oral dosage forms.
SI0948541T1 (sl)	2006-06-30	PTHrP analogi
ZA981029B (en)	1999-08-10	Pharmaceutical agents.
ZA985710B (en)	2000-01-10	Delayed-release dosage forms of sertraline.
ZA9811504B (en)	2000-06-15	Novel pharmaceutical.
ZA976555B (en)	1998-01-30	Synthesis of analogs of PTH and PTHrP.
ZA9811506B (en)	2000-11-06	Novel pharmaceutical.
ZA973209B (en)	1997-11-20	Therapeutic compounds.
ZA989680B (en)	1999-07-23	Pharmaceutical composition.
ZA9811505B (en)	2000-11-06	Novel pharmaceutical.
ZA985709B (en)	2000-01-10	Encapsulated solution dosage forms of sertraline.
ZA974811B (en)	1997-12-30	Novel therapeutic compounds.
ZA987392B (en)	2000-02-17	Pharmaceutical composition.
ZA965494B (en)	1997-12-29	Therapeutic agents.
PL338781A1 (en)	2000-11-20	Dosage form
ZA982255B (en)	1999-09-17	Process for the preparation of arylmalonates.
ZA984609B (en)	1999-11-29	Fungicidal mixture.
ZA985707B (en)	2000-01-10	Sertraline salts and sustained-release dosage forms of sertraline.
ZA982558B (en)	1999-09-27	Novel Pharmaceutical.
GB9718683D0 (en)	1997-11-05	Novel dosage form